Genomic Health Partners with OncoMed on NGS-based Biomarker Discovery; Plans New Hires for InVitae | GenomeWeb

This story was originally published May 3.

Genomic Health said last week that it is partnering with OncoMed Pharmaceuticals to use next-generation sequencing to identify biomarkers that can be applied to the clinical development of OncoMed's cancer therapeutics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.